Navigation Links
Stellar Biotechnologies Analyst Report; Early Mover in Fast Growing Immunotherapy Market by BrokerBank Securities, Inc.
Date:9/5/2014

NEW YORK, Sept. 5, 2014 /PRNewswire/ -- Stellar Biotechnologies, Inc. (OTCQB: SBOTF) is an emerging contender in sustainable manufacture of Keyhole Limpet Hemocyanin (KLH), an important immune-stimulating protein used in wide-ranging therapeutic and diagnostic markets. KLH is both an active pharmaceutical ingredient (API) in many new immunotherapies (targeting cancer, immune disorders, and infectious diseases) as well as a finished product for measuring immune status. Stellar Biotechnologies is unique in its proprietary methods, facilities, and KLH technology. 

The Company's KLH protein is so unique because it can be sourced from the blood of only one rare sea animal, the California Keyhole Limpet which SBOTF farms in its own facility. The Keyhole Limpet can only be found off the coast of central California to Northern Baja. Stellar's headquarters and aquaculture facility are situated in the center of those two locations. This is certainly an advantage that creates entry barriers but also creates big systemic vulnerability issues as well.  How long it takes at maturity to produce the material and the ultimate quality level are still to be learned.  This can be a decided advantage for aggressive traders and speculators but must be carefully considered as a risk for longer term investors.

An analyst report which details the current situation, an overview of the company and analyst comments can be viewed in its entirety by using the link below. There is no cost obligation required to view this report: 

http://bit.ly/-SBOTF-AnalystReport

FORWARD-LOOKING DISCLAIMER   

This report may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward- looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of mentioned company to be materially different from the statements made herein.   

COMPLIANCE PROCEDURE   

Content is researched, written and reviewed on a best-effort basis. Research report provided for informational purposes. This document, article or report is written and authored by Michael Anderegg, Chartered Financial Analyst. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

A full disclaimer can be found by viewing the full analyst report.

BrokerBank Securities, Inc. is a member of the Financial Industry Regulatory Authority, CRD number #130116.


'/>"/>
SOURCE BrokerBank Securities, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. CPhI & CPhI Pharma Evolution Add Stellar Names to Expert Industry Panel
2. Synthetic Biologics and FUJIFILM Diosynth Biotechnologies UK Announce Significant Improvement in API Manufacturing of SYN-004 for the Prevention of C. difficile
3. Pareto Biotechnologies Announces Technology Partnership With DNA2.0, Inc.
4. HedgePath Pharmaceuticals, Inc. Completes Reorganization Plan with Commonwealth Biotechnologies
5. Medical Marijuana Inc. Portfolio Company CanChew BioTechnologies Inc. Announces Final Three Days for Market Survey and Free Product Trial Registration
6. Lifeline Biotechnologies Receives Third Software Patent
7. Lifeline Biotechnologies First Warning Systems
8. Lifeline Biotechnologies, Inc. Receives Patent Award, a Device for Breast Tissue Temperature Analysis for Determining Cancer Conditions
9. The Zacks Analyst Blog Highlights: Powershares Dynamic Pharmaceuticals ETF, SPDR S&P Pharmaceuticals ETF, iShares U.S. Pharmaceuticals and Market Vectors Pharmaceutical
10. The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Franks International
11. Joel Sendek, Leading Wall Street Biotech Analyst, Joins Forward Pharma as Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2020)... ... July 02, 2020 , ... ... is pleased to announce its donation of more than $190,000 in personal protective ... Health and Human Services. As extreme medical shortages continue to plague the nation’s ...
(Date:7/1/2020)... ... 01, 2020 , ... Stratodesk today announced a massive new ... NComputing devices. Thanks to fantastic new growth and stellar adoption of the NoTouch ... that will make the full Stratodesk NoTouch OS branded image available on NComputing ...
(Date:6/25/2020)... ... ... R3 Medical Training announced today it is now enrolling for its new Healthcare ... is August 6-7, 2020 in San Diego and the second is August 20-21, 2020 ... option. , The two day agenda for each course is identical, covering a comprehensive ...
Breaking Medicine Technology:
(Date:7/7/2020)... PORTLAND, Ore. (PRWEB) , ... July 07, 2020 ... ... and a unique one or two head design to efficiently sanitize large surfaces ... https://www.germ-fogger.mx , is now available to support sales in that region. , In ...
(Date:7/2/2020)... ... 02, 2020 , ... Dr. Christine Blaine has earned a stellar ... offices located in Staten Island, Huntington and NYC, NY. Her former Manhattan clinic, ... suite at The Parlor NYC at 160 Madison Avenue. Blaine Plastic Surgery ...
(Date:7/1/2020)... ... July 01, 2020 , ... ABSTRAX, an ... officially released its new terpene infused product line including custom rolling papers, ... enjoy cannabis terpene profiles and flavors worldwide. , “We’ve made it easier than ...
(Date:6/28/2020)... ... June 26, 2020 , ... Medisend College ... high-quality, intensive education and training that prepares graduates for professional careers as field ... of the Board of Trustees. , Ms. Williams currently serves as Associate Vice ...
(Date:6/28/2020)... ... June 27, 2020 , ... The FSHD Society announced ... conference in the organization’s history. The online conference takes the place of FSHD ... cancelled this year due to COVID-19. Nearly 300 individuals and families living with ...
Breaking Medicine News(10 mins):